112 related articles for article (PubMed ID: 7664290)
1. Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer.
Miyake M; Nakano K; Ieki Y; Adachi M; Huang CL; Itoi S; Koh T; Taki T
Cancer Res; 1995 Sep; 55(18):4127-31. PubMed ID: 7664290
[TBL] [Abstract][Full Text] [Related]
2. Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer.
Miyake M; Nakano K; Itoi SI; Koh T; Taki T
Cancer Res; 1996 Mar; 56(6):1244-9. PubMed ID: 8640807
[TBL] [Abstract][Full Text] [Related]
3. Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer.
Higashiyama M; Taki T; Ieki Y; Adachi M; Huang CL; Koh T; Kodama K; Doi O; Miyake M
Cancer Res; 1995 Dec; 55(24):6040-4. PubMed ID: 8521390
[TBL] [Abstract][Full Text] [Related]
4. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
[TBL] [Abstract][Full Text] [Related]
5. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma.
Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C
Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model.
Takeda T; Hattori N; Tokuhara T; Nishimura Y; Yokoyama M; Miyake M
Cancer Res; 2007 Feb; 67(4):1744-9. PubMed ID: 17308116
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
Kuroda N; Inoue K; Guo L; Miyazaki E; Hayashi Y; Naruse K; Toi M; Hiroi M; Shuin T; Enzan H
Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
[TBL] [Abstract][Full Text] [Related]
8. MRP-1/CD9 gene transduction downregulates Wnt signal pathways.
Huang CL; Liu D; Masuya D; Kameyama K; Nakashima T; Yokomise H; Ueno M; Miyake M
Oncogene; 2004 Sep; 23(45):7475-83. PubMed ID: 15334057
[TBL] [Abstract][Full Text] [Related]
9. Suppression of pulmonary metastasis using adenovirally motility related protein-1 (MRP-1/CD9) gene delivery.
Miyake M; Inufusa H; Adachi M; Ishida H; Hashida H; Tokuhara T; Kakehi Y
Oncogene; 2000 Nov; 19(46):5221-6. PubMed ID: 11077438
[TBL] [Abstract][Full Text] [Related]
10. A novel molecular staging protocol for non-small cell lung cancer.
Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of CD151 gene expression in non-small cell lung cancer.
Tokuhara T; Hasegawa H; Hattori N; Ishida H; Taki T; Tachibana S; Sasaki S; Miyake M
Clin Cancer Res; 2001 Dec; 7(12):4109-14. PubMed ID: 11751509
[TBL] [Abstract][Full Text] [Related]
12. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
[TBL] [Abstract][Full Text] [Related]
13. Motility-related protein 1 (MRP-1/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression.
Mhawech P; Herrmann F; Coassin M; Guillou L; Iselin CE
Cancer; 2003 Oct; 98(8):1649-57. PubMed ID: 14534881
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of CD9 does not affect in vivo tumorigenic or metastatic properties of human prostate cancer cells.
Zvieriev V; Wang JC; Chevrette M
Biochem Biophys Res Commun; 2005 Nov; 337(2):498-504. PubMed ID: 16198313
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the G-protein inwardly rectifying potassium channel 1 (GIRK1) in primary breast carcinomas correlates with axillary lymph node metastasis.
Stringer BK; Cooper AG; Shepard SB
Cancer Res; 2001 Jan; 61(2):582-8. PubMed ID: 11212253
[TBL] [Abstract][Full Text] [Related]
17. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA.
Ikeyama S; Koyama M; Yamaoko M; Sasada R; Miyake M
J Exp Med; 1993 May; 177(5):1231-7. PubMed ID: 8478605
[TBL] [Abstract][Full Text] [Related]
18. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.
Wang JC; Bégin LR; Bérubé NG; Chevalier S; Aprikian AG; Gourdeau H; Chevrette M
Clin Cancer Res; 2007 Apr; 13(8):2354-61. PubMed ID: 17406028
[TBL] [Abstract][Full Text] [Related]
20. CD9 expression in gastric cancer and its significance.
Hori H; Yano S; Koufuji K; Takeda J; Shirouzu K
J Surg Res; 2004 Apr; 117(2):208-15. PubMed ID: 15047125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
